Wednesday, 13 August 2014

TRICLOSAN in Colgate Total

A chemical "TRICLOSAN" that has been linked to cancer cell growth, premature birth, reduced fertility & immature cancerous bone (Osteosarcoma) is being used by millions in Bharat while brushing their teeth every morning using  "Colgate Total" toothpaste.

US FDA approved " "Colgate Total" with poison"Triclosan" in 1997 despite studies clearly indicated massive cancerous activity in animals in Lab by shamelessly accepting studies by company in vested interest in Triclosan which found it safe on human.

These 35 page approval documents which were released recently after a Freedom of Information Act lawsuit last year, reveals the FDA had noted serious concerns that Triclosan could increase the risk of cancerous growth, immature bone, premature birth - but Colgate MNC diabolically convinced them that "Triclosan" was only problematic in large doses.

The recently released pages, taken alongside new research on triclosan, raise questions about whether the agency did  due diligence or was managed in approving Colgate Total 17 years ago. Shockingly some pages in the report showing how tests found bone malformations in mice and rats. 

Experts like Dr Thomas Zoeller
believe that if we have studies on animals that suggest any chemical is carcinogenic, Why take huge risk by approving it for human.

Colgate is still adamant that the 35 pages do not prove the chemical is harmful to humans and it has no plans to reformulate Colgate "Total" toothpaste.

The results found in animals has now given FDA enough reasons to run tests again to review the dangers of the chemical. 

In a sign of the concern over the chemical, Minnesota lawmakers banned the chemical in May. Avon and Johnson & Johnson have also announced plans to cut the chemical from its products.

In 2010, the European Union banned triclosan in materials that come into contact with food.

Read more: http://www.dailymail.co.uk/news/article-2722289/Chemical-used-Colgate-Total-toothpaste-linked-cancer.html#ixzz3A8ojFOhb

No comments:

Post a Comment